AllPortfolio news Alentis raises 12.5 million Swiss francs The Basel-based biotech company Alentis Therapeutics AG has successfully concluded a CHF 12.5 million Series A financing co-lead by BioMedPartners and BB Pureos Bioventures and joined by…Jérémie Meyer03.03.2020